Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
US-12552836-B2 · Feb 17, 2026 · US
Protagonist Therapeutics Inc holds 113 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 113 |
| Recent patents | 39 |
| First publication | Feb 4, 2016 |
| Latest publication | Feb 17, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12552836-B2 · Feb 17, 2026 · US
US-2026000659-A1 · Jan 1, 2026 · US
US-2025361280-A1 · Nov 27, 2025 · US
US-2025360187-A1 · Nov 27, 2025 · US
US-12478617-B2 · Nov 25, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12552836-B2 · Feb 17, 2026 · US
US-2026000659-A1 · Jan 1, 2026 · US
US-2025361280-A1 · Nov 27, 2025 · US
US-2025360187-A1 · Nov 27, 2025 · US
US-12478617-B2 · Nov 25, 2025 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 112 |
| Chemistry & Metallurgy | 112 |
| Physics | 16 |
| Cross-Sectional Technologies | 4 |
Answers are generated from the same data shown on this page.